DrugPatentWatch Database Preview
Details for Patent: 10,179,216
» See Plans and Pricing
Which drugs does patent 10,179,216 protect, and when does it expire?
Patent 10,179,216 protects XHANCE and is included in one NDA.
This patent has fifteen patent family members in twelve countries.
Summary for Patent: 10,179,216
| Title: | Nasal delivery devices |
| Abstract: | A nasal delivery device comprising: a housing (15); a nosepiece (17) for fitting to a nasal cavity of a subject; a mouthpiece (19) through which the subject in use exhales; and a substance supply unit (21) including an actuation member (23) which extends from one end of the housing and is manually actuated to deliver substance to the nasal cavity of the subject; wherein the housing includes a grip section (27) which is disposed at the one end of the housing from which the actuation member extends, said grip section comprising a first, distal part (28) including at least one projecting grip element (29) by which the subject grips the housing in actuating the actuation member, and a second, proximal part (31) providing a recess (33) in which fingers of the subject are located, said recess promoting proper orientation of the delivery device in a hand of the subject. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Dudgeon; Kate (Providence, RI), Gordon; Joseph (Mansfield, MA), Guarraia; Mark (Cranston, RI), Leclerc; Michael (Cranston, RI), Mahmoud; Ramy A (Skillman, NJ) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 14/380,836 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 10,179,216
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,179,216
| PCT Information | |||
| PCT Filed | February 25, 2013 | PCT Application Number: | PCT/EP2013/053748 |
| PCT Publication Date: | August 29, 2013 | PCT Publication Number: | WO2013/124493 |
International Family Members for US Patent 10,179,216
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2865355 | Start Trial | |||
| China | 104428024 | Start Trial | |||
| Denmark | 2817053 | Start Trial | |||
| European Patent Office | 2817053 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
